Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2006 2
2007 2
2008 1
2009 2
2011 1
2012 3
2013 2
2014 2
2015 2
2017 1
2018 2
2019 5
2020 3
2021 5
2022 2
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Molecular Clusters and Tumor-Immune Drivers of IgM Monoclonal Gammopathies.
Mondello P, Paludo J, Novak JP, Wenzl K, Yang ZZ, Jalali S, Krull JE, Braggio E, Dasari S, Manske MK, Abeykoon JA, Sarangi V, Kapoor P, Paulus A, Reeder CB, Ailawadhi S, Chanan-Khan AA, Kyle RA, Gertz MA, Novak AJ, Ansell SM. Mondello P, et al. Among authors: yang zz. Clin Cancer Res. 2023 Mar 1;29(5):957-970. doi: 10.1158/1078-0432.CCR-22-2215. Clin Cancer Res. 2023. PMID: 36534518
T-cell phenotype including CD57+ T follicular helper cells in the tumor microenvironment correlate with a poor outcome in follicular lymphoma.
Yang ZZ, Kim HJ, Wu H, Tang X, Yu Y, Krull J, Larson DP, Moore RM, Maurer MJ, Pavelko KD, Jalali S, Pritchett JC, Mudappathi R, Wang J, Villasboas JC, Mondello P, Novak AJ, Ansell SM. Yang ZZ, et al. Blood Cancer J. 2023 Aug 18;13(1):124. doi: 10.1038/s41408-023-00899-3. Blood Cancer J. 2023. PMID: 37591873 Free PMC article.
Molecular classification and identification of an aggressive signature in low-grade B-cell lymphomas.
Hopper MA, Wenzl K, Hartert KT, Krull JE, Dropik AR, Novak JP, Manske MK, Serres MR, Sarangi V, Larson MC, Maurer MJ, Yang ZZ, Paludo J, McPhail ED, Habermann TM, Link BK, Rimsza LM, Ansell SM, Cerhan JR, Jevremovic D, Novak AJ. Hopper MA, et al. Among authors: yang zz. Hematol Oncol. 2023 Oct;41(4):644-654. doi: 10.1002/hon.3187. Epub 2023 May 30. Hematol Oncol. 2023. PMID: 37254453
Follicular lymphoma B cells exhibit heterogeneous transcriptional states with associated somatic alterations and tumor microenvironments.
Krull JE, Wenzl K, Hopper MA, Manske MK, Sarangi V, Maurer MJ, Larson MC, Mondello P, Yang Z, Novak JP, Serres M, Whitaker KR, Villasboas Bisneto JC, Habermann TM, Witzig TE, Link BK, Rimsza LM, King RL, Ansell SM, Cerhan JR, Novak AJ. Krull JE, et al. Cell Rep Med. 2024 Mar 19;5(3):101443. doi: 10.1016/j.xcrm.2024.101443. Epub 2024 Feb 29. Cell Rep Med. 2024. PMID: 38428430 Free PMC article.
Targeting of inflammatory pathways with R2CHOP in high-risk DLBCL.
Hartert KT, Wenzl K, Krull JE, Manske M, Sarangi V, Asmann Y, Larson MC, Maurer MJ, Slager S, Macon WR, King RL, Feldman AL, Gandhi AK, Link BK, Habermann TM, Yang ZZ, Ansell SM, Cerhan JR, Witzig TE, Nowakowski GS, Novak AJ. Hartert KT, et al. Among authors: yang zz. Leukemia. 2021 Feb;35(2):522-533. doi: 10.1038/s41375-020-0766-4. Epub 2020 Mar 5. Leukemia. 2021. PMID: 32139889 Free PMC article. Clinical Trial.
40 results